Crescent Biopharma, Inc. Common Stock
$17.88
USD
Last updated on --.
24h volume181.95K
24h highest19.0500 USD
24h lowest17.8300 USD
24h Price movement-2.51%
CBIO recent prices
24 Hours
-2.51%-$0.46
30 days
-6.68%-$1.310
60 days
+1.72%+$0.31
90 days
+56.98%+$6.370
Key data
Previous close18.3400 USD
Market cap496.35M USD
Volume181.95K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-5.1600 USD
Net income (FY)-162.08M USD
Revenue (FY)11.88M USD
Last report dateApr 29, 2026
About Crescent Biopharma, Inc. Common Stock
HeadquartersWALTHAM
Employees (FY)44.00
Revenue per employee (FY)270.07K USD
Net income per employee (FY)-3.68M USD
Listed onNasdaq
CBIO conversion tables
 |  |
|---|---|
| 0.5 CBIO | 8.940 USD |
| 1 CBIO | 17.88 USD |
| 5 CBIO | 89.4 USD |
| 10 CBIO | 178.8 USD |
| |
|---|---|
| 0.5 USD | 0.027964 CBIO |
| 1 USD | 0.055928 CBIO |
| 5 USD | 0.27964 CBIO |
| 10 USD | 0.55928 CBIO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CBIO is trading at $17.88, -2.51% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CBIO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CBIO is currently trading at $17.88, -2.51% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CBIO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CBIO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CBIO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CBIO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Crescent Biopharma, Inc. Common Stock's market cap is currently 496.35M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume181.95K
24h highest19.0500 USD
24h lowest17.8300 USD
24h Price movement-2.51%
Start trade with CBIO Perpetual
Sign up to trade